Roche’s bid to retool Actemra for COVID-19 fails

0
1

ZURICH: Roche’s attempt to retool its rheumatoid arthritis drug Actemra/RoActemra to treat patients hospitalised with severe COVID-19-related pneumonia has failed in a late-stage trial, the Swiss company said on Wednesday. Roche launched the 330-patient trial in March as it joined other pharmaceutical companies seeking to re-purpose existing medicines to fight the pandemic.

NO COMMENTS